Drug intelligence / Profile preview

cyclosporin + mycophenolate mofetil + antilymphocyte serum

Development stage
Unknown
Lead developer
Sandoz
Modality
Small Molecules
Administration
Intravenous, Oral
01

Overview

This is a combination immunosuppressive regimen consisting of cyclosporin, mycophenolate mofetil, and antilymphocyte serum. Cyclosporin is a cyclic peptide derived from soil fungi that inhibits T cell function by blocking calcineurin, thereby suppressing the immune response[5]. Mycophenolate mofetil is an antimetabolite immunosuppressant that inhibits inosine monophosphate dehydrogenase, leading to suppression of lymphocyte proliferation. Antilymphocyte serum (ALS), also known as anti-lymphocyte globulin or antithymocyte globulin depending on the preparation, consists of polyclonal antibodies (usually from horse or rabbit) directed against human lymphocytes; it acts by binding to and depleting circulating lymphocytes through complement-mediated lysis and opsonization for phagocytosis[1][4][5]. This combination is primarily used in organ transplantation to prevent rejection by providing potent multi-modal immunosuppression.

02

Targets

IMPDH (Inosine-5'-monophosphate dehydrogenase 1)CN (Calcineurin)

Beyond the preview

Go deeper on cyclosporin + mycophenolate mofetil + antilymphocyte serum.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cyclosporin + mycophenolate mofetil + antilymphocyte serum.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call